-
Mashup Score: 7
Join us for a captivating live panel discussion examining the underlying processes of Alzheimer’s disease (AD) progression. In particular, the panelists will consider the role of protofibrils in amyloid plaque formation and neurodegeneration. Esteemed neurology specialists Dennis Selkoe, MD, Co-Director of the Center for Neurologic Diseases at Brigham and Women’s Hospital, and Arif Dalvi, MD, MBA, Director, Memory Disorders Center at St. Mary’s Medical Center, will join session moderator Michael Irizarry, MD, MPH, SVP of Clinical Research and Deputy Chief Clinical Officer of Neurology at Eisai, for this special half-hour live event. Tap or click the Register button to RSVP. For information about Eisai’s AD research, please visit: https://us.eisai.com/our-science/disease-areas/neurology/ADdementia?_ga=2.129827148.1340094559.1688652989-1360014753.1663104070&utm_medium=social&utm_source=linkedin For more info about Biogen, please visit: www.biogen.com/disease-areas/alzheimers-disease.html
Source: www.linkedin.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6
Join us for a captivating live panel discussion examining the underlying processes of Alzheimer’s disease (AD) progression. In particular, the panelists will consider the role of protofibrils in amyloid plaque formation and neurodegeneration. Esteemed neurology specialists Dennis Selkoe, MD, Co-Director of the Center for Neurologic Diseases at Brigham and Women’s Hospital, and Arif Dalvi, MD, MBA, Director, Memory Disorders Center at St. Mary’s Medical Center, will join session moderator Michael Irizarry, MD, MPH, SVP of Clinical Research and Deputy Chief Clinical Officer of Neurology at Eisai, for this special half-hour live event. Tap or click the Register button to RSVP. For information about Eisai’s AD research, please visit: https://us.eisai.com/our-science/disease-areas/neurology/ADdementia?_ga=2.129827148.1340094559.1688652989-1360014753.1663104070&utm_medium=social&utm_source=linkedin For more info about Biogen, please visit: www.biogen.com/disease-areas/alzheimers-disease.html
Source: www.linkedin.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Visit MadeofMore.com - 29 day(s) ago
Explore this initiative designed to provide resources and community for those affected by head and neck cancer.
Source: www.madeofmore.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 5Understanding and supporting Kidney Cancer | Eisai US - 1 month(s) ago
Eisai employees reflect on Kidney Cancer Awareness Month by offering perspectives on insights, symptoms, challenges, and ways to support. Join us in empowering patients.
Source: us.eisai.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 10Assistance in Action - Magnolia Paws for Compassion® - 3 month(s) ago
Service dogs are rigorously trained, starting as puppies, to perform tasks and provide support for people living with a number of different health conditions.
Categories: General Medicine News, PayerTweet-
Eisai’s Magnolia Paws for Compassion has helped provide 24 #SeizureAssistanceDogs to people in need, including Hannah, who’s living with a rare form of #epilepsy. Hannah's dog, Yuki, is specifically trained to help her during seizures. More at https://t.co/dTRIkBoDup #EpilepsyDay https://t.co/Wn7iSzenP0
-
-
Mashup Score: 7Cancer Screening Quiz - 3 month(s) ago
Learn what cancers screenings are right for you with our simple quiz!
Source: quiz.typeform.comCategories: General Medicine News, PayerTweet-
This #CancerPreventionMonth, Eisai is amplifying @PreventCancer tools to help you develop healthier lifestyles. Take the screening quiz to learn how you can reduce your risk of certain types of cancer & discover the cancer screenings needed at every age. https://t.co/cZYPhphzzz https://t.co/mWBii8MyB0
-
-
Mashup Score: 9An oncologist's perspective on World Cancer Day | Eisai US - 3 month(s) ago
Oncologist Corina Dutcus reflects on World Cancer Day and how her work at Eisai has impacted the oncology space through the development of treatments and support programs.
Source: us.eisai.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7How Fast Can We Solve Alzheimer’s? - 3 month(s) ago
How Fast Can We Solve Alzheimer’s? – Wednesday, January 31, 2024
Categories: General Medicine News, PayerTweet
-
Mashup Score: 5Eisai Aims to Advance Genitourinary Cancer Treatment with New Research at ASCO GU 2024 - 3 month(s) ago
Data from the Pivotal Phase 3 CLEAR Trial and Phase 2 KEYNOTE-B61 Trial Provide Further Insight into the Role of Lenvatinib Plus Pembrolizumab as a First-Line Treatment Option for Patients with…
Source: media-us.eisai.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6Eisai Furthers Oncology Research in Gastrointestinal Cancer Treatment with New Data at ASCO GI 2024 - 3 month(s) ago
Longer-Term Efficacy and Safety Results from the Phase 3 LEAP-002 Trial Offer Additional Information About the First-Line Treatment of Patients with Unresectable Hepatocellular Carcinoma Data on…
Source: media-us.eisai.comCategories: General Medicine News, PayerTweet
You still have an opportunity to watch the most-recent LinkedIn Live panel discussion @eisaiusneuro cohosted with @Biogen. Follow the link to stream an encore presentation of “Understanding the Role of Protofibrils in Alzheimer’s Disease.” https://t.co/uRtEdDcCXX